CG heads into the week with an unusual split: options traders are the most defensively positioned they've been in months, yet short sellers have been quietly covering.
The clearest tension is in options. The put/call ratio has climbed to 1.17, more than two standard deviations above its 20-day average of 1.04 — a reading that puts it near the highest defensive tilt of the past year. That shift is recent and sharp: through most of May, the PCR was running in the 0.95–1.03 range, and it only broke meaningfully higher in the second week of June. Options traders are paying noticeably more for downside protection right now than they have all year.
Short interest tells a different story. Bears have been reducing exposure — short interest fell roughly 8.5% over the week to 4.5% of the free float, reversing a brief spike in early June that had pushed positions above 17.6 million shares. Borrowing costs remain subdued at 0.50%, and the lending pool is wide open: availability is running above 620% of outstanding short interest, well inside the normal range and far from anything resembling squeeze conditions. The ORTEX short score has drifted lower too, easing from 50.4 two weeks ago to 48.6 today — a signal the market has moved off a modestly bearish posture toward something more neutral.
The Street is broadly cautious, with targets drifting lower across the board. JPMorgan and Barclays both trimmed price targets following the Q1 print — JPMorgan to $63, Barclays to $63 — while maintaining their ratings. TD Cowen took a more decisive step, downgrading from Buy to Hold and cutting its target from $54 to $50 in May. Goldman Sachs held its Buy rating but pulled its target down sharply to $69 from $81 back in April, a meaningful reset even if that move is now six weeks old. The consensus mean target of $60.38 implies around 29% upside from the current $46.83 price. The price-to-earnings multiple is running at roughly 10x, and price-to-book has expanded about 15% over the past 30 days as the stock partially recovered from its May lows. A forward EPS growth revision factor scoring in the 83rd percentile is notable — forward estimates have moved sharply higher — yet the earnings surprise factor ranks in just the 8th percentile, a reminder that Carlyle has struggled to beat expectations in practice despite improving forecasts.
The ownership picture adds context. Carlyle's three co-founders — Daniel D'Aniello, David Rubenstein, and William Conway — together hold around 24% of shares outstanding, and all three reported zero change in their stakes as of April. That stability is worth noting given the stock's 18% YTD underperformance versus peers. Millennium Management trimmed its position by 1.6 million shares in Q1, while Harris Associates added nearly 1.4 million and Capital Research added around 820,000 — a modest tug of war at the institutional level rather than a clear directional shift.
Earnings are not due until August 6, and the recent track record offers little comfort for momentum traders: the last two prints both produced negative one-day and five-day reactions, the most recent delivering a 2.2% one-day drop. Close peers BX and TPG gained 6.3% and 3.4% respectively on the week, outpacing CG's 3.7% bounce and underscoring a gap in investor enthusiasm that has persisted since the start of the year. The setup heading into the next few weeks is therefore less about whether short interest is a threat — it isn't — and more about whether the spike in put demand reflects something fundamental that the options market is pricing before the broader equity market catches up.
See the live data behind this article on ORTEX.
Open CG on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
